Aphria Inc.’s U.S.-listed shares rose about 3% Tuesday, after news that the company has achieved GMP status in the European Union, clearing the path for it to start selling medical cannabis to pharmacies in Germany and other countries.
The green rush in the global cannabis market continued in 2019, with sales doubling in seven U.S. states as well as Canada, and you can expect that trend to continue this year, a report out on Thursday shows.
The report from Arcview Market Research and BDS Analytics shows global cannabis sales rose 48% to $15 billion in 2019.
The figures, which are still preliminary and may get revised as more data comes in, were bolstered by states where cannabis has recently become legal for adult or medicinal use.
Global cannabis sales rose 48% to $15 billion in 2019, driven by growth in sales in Canada and seven U.S. states that saw sales more than double.
A recently published article in the journal Scientific Reports has described the remarkable discovery of a previously unknown cannabinoid. Dubbed THCP, the molecule has been shown to be significantly more potent that its well-known counterpart THC, however, it’s still unclear how psychoactive it is in humans or how present it is in popular cannabis varieties.
Cannabis companies are poised to see sales grow by nearly nine times through 2030 as legalisation gains popularity and distribution widens, according to Morningstar’s latest research.
Europe got its first cannabis exchange-traded fund this week. The news is as much a sign of pressures in the North American pot industry as one of pent-up demand among European investors.
Europe is poised to see the first launch of an ETF (exchange traded fund) that is dedicated to the cannabis sector. It is being co-sponsored by HANetf and Purpose Investments of Canada. The Medical Cannabis and Wellness ETF is scheduled to launch on Deutsche Boerse in Frankfurt in the week of 13 January, according to HANetf.
NONTHABURI, Thailand (AP) — Thailand on Monday opened its first two full-time clinics dispensing cannabis oil for medical treatment, a step forward in the government’s policy of promoting the licensed use of marijuana products to relieve the symptoms of a range of ailments.
About 400 patients, many of them with cancer, were given the oil for free at a flagship clinic at the Public Health Ministry in a suburb of Bangkok.
Germany's drug commissioner on Tuesday called for a nationwide standard for the amount of cannabis allowed for personal possession.
Daniela Ludwig told the Funke Media Group that it is "difficult" when each German state has different regulations.
QUITO, Ecuador (AP) — Unrelenting pain in her hips and weeks of insomnia left Nelly Valbuena desperate for relief from her metastatic breast cancer.
The university professor found freedom from her disease’s cruel side effects in an unexpected remedy: CBD, a compound extracted from the cannabis plant.
Now Valbuena is pushing Ecuador’s government to put into effect recently passed legislation permitting medicinal use of cannabis products so others like her suffering from agonizing illnesses can have new options for pain relief.
